The aim of this study was to measure the levels of Tregs and their related cytokines (IL10, IL35, and TGF-β) in the peripheral blood of patients with probable AD and to understand the Treg-related immunosuppression status at different stages of AD. The gene discussed is TGFB1; the disease is Alzheimer disease.